| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/26/1999 | US5863943 Stabilized skin conditioner with alpha hydroxy acids |
| 01/26/1999 | US5863942 Retinoid conjugate compounds useful for the treatment of aging skin |
| 01/26/1999 | US5863941 Method and composition of a topical treatment of inner ear and labyrinth symptoms |
| 01/26/1999 | US5863940 Medicament and therapeutical method for treating idiopathic asthenozoospermia |
| 01/26/1999 | US5863938 Wound healing agent comprises pyruvate selected from the group consisting of pyruvic acid, pharmaceutically acceptable salts of pyruvic acid and mixtures thereof; antioxidant; mixture of saturated and unsaturated fatty acids |
| 01/26/1999 | US5863935 Synthesis of indole derivatives of heterocyclic compounds for treatment of headaches and migraines |
| 01/26/1999 | US5863934 Use of lofexidine in the treatment of behavioral disorders |
| 01/26/1999 | US5863931 Amidino derivatives and their use as nitric oxide synthase inhibitors |
| 01/26/1999 | US5863930 Atherosclerosis treatment formed by reaction of pyridones with biphenylmethyl halogen |
| 01/26/1999 | US5863929 Anticoagulant agents |
| 01/26/1999 | US5863927 Dextromethorphan and an oxidase inhibitor for treating intractable conditions |
| 01/26/1999 | US5863926 4,4-(disubstituted)cyclohexan-1-carboxylate monomers and related compounds |
| 01/26/1999 | US5863925 Use of sulbutiamine in the treatment of Parkinson's disease, schizophrenia, alcoholism, and dysthymia |
| 01/26/1999 | US5863924 5ht2b antagonist |
| 01/26/1999 | US5863923 Treatment of anxiety, psychosis, schizophrenia, drug abuse, irritable bowel syndrome |
| 01/26/1999 | US5863922 An analgesics mixture comprising acetaminophen, sedative butalbital and a n-methyl-d-aspartate receptor antagonist selected from dextrorphan, dextromethorphan |
| 01/26/1999 | US5863921 Purine and guanine derivatives |
| 01/26/1999 | US5863918 Naphthalene derivatives |
| 01/26/1999 | US5863917 Anxiolytic agent, anticonvulsants, analgesics and neuroprotectives. |
| 01/26/1999 | US5863916 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/NMDA receptor |
| 01/26/1999 | US5863914 Administering to human n,n-dimethylbenzene or n,n-dimethylnaphthalene-cyclic urea derivative to treat a disease-state caused by inhibition of factor xa |
| 01/26/1999 | US5863913 Aromatic compound and pharmaceutical composition |
| 01/26/1999 | US5863912 Method of treatment of hormone-unresponsive metastiatic prostate cancer |
| 01/26/1999 | US5863910 Treatment of chronic inflammatory disorders of the gastrointestinal tract |
| 01/26/1999 | US5863906 Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man |
| 01/26/1999 | US5863905 2',5'-phosphorothioate/phosphodiester oligoadenylates and anti-viral uses thereof |
| 01/26/1999 | US5863904 Methods for treating cancers and restenosis with P21 |
| 01/26/1999 | US5863777 DNA encoding alanyl tRNA synthetase from streptococcus pneumonine |
| 01/26/1999 | US5863771 Sugar, food and process of forming sugar |
| 01/26/1999 | US5863757 An expression vector comprising polynucleotide having an open reading frame operably linked to a promoter and encoding a specific polypeptide |
| 01/26/1999 | US5863716 Treatment of plasmodium |
| 01/26/1999 | US5863582 Washing vegetables or fruits with water treated with ion exchange resins to remove nitrate and nitrite ions, pulverizing, adding nutritional supplements |
| 01/26/1999 | US5863563 Administering a ph-raising buffer in powder form |
| 01/26/1999 | US5863562 Methods and composition for preserving media in the tip of a solution dispenser |
| 01/26/1999 | US5863559 Oral dosage form for treating migraine |
| 01/26/1999 | US5863558 Administering a controlled release antiepileptic drug wherein the dosage form comprising a nonionic protective film for protecting from fluid of the gastrointestinal environment |
| 01/26/1999 | US5863551 Implantable polymer hydrogel for therapeutic uses |
| 01/26/1999 | US5863550 Administering injection of an aqueous solution of water-soluble tauroursoxydecholic acid; liver disorders; side effect reduction |
| 01/26/1999 | US5863544 Consists of hydroxy acid, polysiloxane and polyol alkyl ester; useful for therapeutical treatment of acne, mycosis, seborrhoeic dermatitis, eczema, rosacea, cutaneous aging or scalp or nail maladies |
| 01/26/1999 | US5863536 N-acetylated alpha-linked acidic dipeptidase (naaladase) enzyme inhibitor for the treatment of glutamate abnormalities and associated nervous tissue ischemia in a animal and for treatment of prostate disease |
| 01/26/1999 | CA2166901C 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them |
| 01/26/1999 | CA2166692C Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 01/26/1999 | CA2136843C Sugar-free dry mix cellulose ether compositions as bulk laxatives |
| 01/26/1999 | CA2132829C Novel derivatives of 2,3-dihydro-benzofuranols |
| 01/26/1999 | CA2131373C 2-aminosugar derivatives of macrolides |
| 01/26/1999 | CA2129505C Novel zirconium salts and their synthesis |
| 01/26/1999 | CA2091049C Prophylactic and remedial preparation for diseases attendant on hyperglycemia, and wholesome food |
| 01/26/1999 | CA2066364C Psychoactive propargylamine derivatives |
| 01/26/1999 | CA2065773C Gastroresistant pharmaceutical formulations for oral administration containing bile acids |
| 01/26/1999 | CA2059865C Pharmaceutical compositions containing orally absorbable glycosaminoglycans |
| 01/26/1999 | CA2006511C Percutaneous preparation of tulobuterol |
| 01/26/1999 | CA2001714C Serine analogs of bu-3608 antibiotics |
| 01/26/1999 | CA2000786C 3-piperidinyl-1,2-benzisoxazoles |
| 01/26/1999 | CA1340354C Periodontium-regenerative materials |
| 01/26/1999 | CA1340344C Steroids containing a 3, 4 or 6 membered spiranic cycle in 17 position, process and intermediates for preparing the same, use thereof as therapeutic agents and pharmaceutical compositions containing them |
| 01/26/1999 | CA1340342C 17-arylsteroids, process and intermediates for preparing the same, use therof as therapeutic agents and pharmaceutical compositions containing them |
| 01/26/1999 | CA1340332C Process for producing optically active benzene-sulfonamide derivatives |
| 01/25/1999 | CA2238664A1 Novel regulator |
| 01/25/1999 | CA2238655A1 Cdna clone my1 that encodes a novel human 7-transmembrane receptor |
| 01/23/1999 | CA2238679A1 Novel phes |
| 01/23/1999 | CA2238674A1 Novel tetracycline resistance protein |
| 01/23/1999 | CA2238665A1 Novel reductase |
| 01/23/1999 | CA2238611A1 Novel lyss |
| 01/23/1999 | CA2238608A1 Novel cyss |
| 01/21/1999 | WO1999002989A1 Chaperone fragments |
| 01/21/1999 | WO1999002732A1 Antisense oligonucleotide inhibition of ras |
| 01/21/1999 | WO1999002701A1 Pak kinase genes and polypeptides and methods of use thereof |
| 01/21/1999 | WO1999002696A1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
| 01/21/1999 | WO1999002673A2 Antisense oligonucleotide sequences as inhibitors of microorganisms |
| 01/21/1999 | WO1999002667A1 Mutations in the myostation gene cause double-muscling in mammals |
| 01/21/1999 | WO1999002666A2 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 01/21/1999 | WO1999002665A1 Nanocrystalline formulations of human immunodeficiency virus (hiv) protease inhibitors using cellulosic surface stabilizers and methods of making such formulations |
| 01/21/1999 | WO1999002654A1 Isolation of bone and cartilage precursor cells |
| 01/21/1999 | WO1999002550A1 Ctl epitopes from ebv |
| 01/21/1999 | WO1999002548A1 A preparation derived from shark cartilage for treatment of diseases related to excessive phf or excessive intracellular calcium |
| 01/21/1999 | WO1999002547A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 01/21/1999 | WO1999002546A1 123 human secreted proteins |
| 01/21/1999 | WO1999002545A2 Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 01/21/1999 | WO1999002542A1 New formulation |
| 01/21/1999 | WO1999002541A2 Erythromycin a oxime solvates |
| 01/21/1999 | WO1999002539A1 Diphosphonic acid salts for the treatment of osteoporosis |
| 01/21/1999 | WO1999002530A1 A process of manufacturing camptothecin derivatives |
| 01/21/1999 | WO1999002529A1 Preparation of oxymorphone, oxycodone and derivatives |
| 01/21/1999 | WO1999002528A1 Novel compounds |
| 01/21/1999 | WO1999002526A1 Tropane analogs and methods for inhibition of monoamine transport |
| 01/21/1999 | WO1999002525A1 Thiadiazolyl and oxadiazolyl phenyl oxazolidinone antibacterial agents |
| 01/21/1999 | WO1999002523A1 2,4,4-trisubstituted-1,3-dioxolane antifungals |
| 01/21/1999 | WO1999002520A1 Diamine derivatives and pharmaceutical containing the same |
| 01/21/1999 | WO1999002519A1 4,5-DIHYDRO-[1H]-BENZ[g]INDAZOLE-3-CARBOXYLIC ACID DERIVATIVES |
| 01/21/1999 | WO1999002517A1 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy |
| 01/21/1999 | WO1999002516A1 Compounds derived from thophene and benzothiophene, and related utilisation and composition |
| 01/21/1999 | WO1999002514A2 Epothilone derivatives |
| 01/21/1999 | WO1999002510A1 Matrix metalloproteinase inhibitors |
| 01/21/1999 | WO1999002506A1 5-(3-phenyl-3-oxo-propyl)-1h-tetrazole derivatives |
| 01/21/1999 | WO1999002505A1 Il-5 inhibiting 6-azauracil derivatives |
| 01/21/1999 | WO1999002504A1 6-azauracil derivatives as il-5 inhibitors |
| 01/21/1999 | WO1999002503A1 Triazole compounds and the use thereof as dopamine-d3-ligands |
| 01/21/1999 | WO1999002502A2 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation |
| 01/21/1999 | WO1999002501A1 Novel compounds |
| 01/21/1999 | WO1999002500A1 Resolution of amines |